Emily Fan
About Emily Fan
Emily Fan is the Associate Director of R&D Strategy and Planning at Bristol Myers Squibb in Shanghai, with extensive experience in clinical research and strategic project management across several leading pharmaceutical companies.
Current Role at Bristol Myers Squibb
Emily Fan holds the position of Associate Director, R&D Strategy and Planning at Bristol Myers Squibb, located in Jing'an District, Shanghai, China. She has been with the company since April 2018, where she focuses on developing and implementing research and development strategies. Her responsibilities include coordinating R&D projects, optimizing resource allocation, and ensuring alignment with the company's long-term goals. Her role is critical in driving innovation and improving the efficiency of R&D operations.
Previous Experience at Hansoh Pharmaceutical Group
Prior to her current role, Emily Fan served as Senior Manager of Strategic Project Management at Jiangsu Hansoh Pharmaceutical Group Co., Ltd. from 2016 to 2018 in Shanghai. In this capacity, she managed high-impact strategic projects, overseeing their planning, execution, and completion. Her work involved collaborating with cross-functional teams to ensure project milestones were met on time and within budget. This experience honed her skills in strategic planning and project management within the pharmaceutical industry.
Roles at Roche and Bayer Pharmaceuticals
Emily Fan's career includes a brief tenure at Roche as Country Study Manager in 2016, and an extensive period at Bayer Pharmaceuticals, where she was the Country Lead Monitor (Program CLM) from 2009 to 2016 in Shanghai. At Roche, her role involved coordinating clinical studies to ensure compliance with regulatory standards. At Bayer, she was responsible for overseeing the monitoring of clinical trials, ensuring data integrity, and maintaining adherence to trial protocols. These roles provided her with substantial experience in clinical research and trial management.
Educational Background
Emily Fan possesses an impressive educational background that complements her professional experience. She earned a Bachelor's degree in Chinese Medicine from Chengdu University of Traditional Chinese Medicine, providing her with a solid foundation in pharmacology and life sciences. Later, she achieved two Master's degrees: one in Finance from Shanghai University of Finance and Economics, and an MBA from Webster University, both completed between 2016 and 2018. This combination of traditional medicine and financial education equips her with unique insights and skills valuable to the pharmaceutical industry.
Initial Career and Early Roles
Emily Fan began her career with roles that laid the foundation for her expertise in clinical research and regulatory affairs. She worked as a Senior Clinical Research Associate at Excel PharmaStudies Inc. from 2008 to 2009, focusing on the execution of clinical trials. Before that, she spent three years from 2005 to 2008 as an Associate Medical Editor and Drug Officer at Pharmacoepidemiology Journal and Hubei Provincial Food and Drug Administration (PFDA) in Wuhan. These initial positions provided her with a deep understanding of drug development processes and regulatory requirements.